The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation
2017 · Scientific Reports · 148 citations
https://doi.org/10.1038/s41598-017-15183-1
A
Andrew S. Brohl
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
305
Papers
5.5K
Citations
32
h-index
66
i10-index
Andrew S. Brohl is an academic researcher from Moffitt Cancer Center. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Polyomavirus and related diseases & Immunotherapy and Immune Responses. The author has an h-index of 32, co-authored 260 publications.
ORCID: 0000-0002-0071-0534Papers by this author
worksThree-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
2021 · Journal for ImmunoTherapy of Cancer · 140 citations
https://doi.org/10.1136/jitc-2021-002478
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
2022 · The Lancet · 126 citations
https://doi.org/10.1016/s0140-6736(22)01659-2
Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Genome Medicine · 87 citations
https://doi.org/10.1186/s13073-016-0313-0
Immuno-transcriptomic profiling of extracranial pediatric solid malignancies
2021 · Cell Reports · 71 citations
https://doi.org/10.1016/j.celrep.2021.110047
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
2021 · ESMO Open · 61 citations
https://doi.org/10.1016/j.esmoop.2021.100290
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat